SB 1750: International Drug Reference Pricing
GENERAL BILL by Gruters
International Drug Reference Pricing; Providing legislative policy; requiring prescription drug manufacturer permitholders to annually report certain international price data to the Agency for Health Care Administration; providing for administrative enforcement by a specified fine and permit suspension; requiring the agency to contract with an entity to designate reference price source countries and establish the reference prices for prescription drugs based on certain criteria; requiring the agency contractor to reevaluate the designated reference prices source countries annually and revise, as needed, etc.
Last Action: 3/8/2024 Senate - Died in Health Policy
Bill Text: Web Page | PDF
- Health Policy (HP)
- Appropriations Committee on Health and Human Services (AHS)
- Fiscal Policy (FP)
Bill History
Date | Chamber | Action |
---|---|---|
1/5/2024 | Senate |
• Filed |
1/11/2024 | Senate |
• Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy • Introduced |
3/8/2024 | Senate |
• Died in Health Policy |